产品
编 号：F518021
分子式：C206H305N51O66
分子量：4551.93
分子式：C206H305N51O66
分子量：4551.93
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
结构图
CAS No: 914454-00-5
产品详情
生物活性：
Enfuvirtide (T20; DP178) acetate is an anti-HIV-1 fusion inhibitor peptide.
体内研究：
Enfuvirtide has a T1/2 of 3.8 h.
体外研究：
A cell-cell fusion assay reveals that the effective concentration for achieving 50% inhibition (IC50) of Enfuvirtide is 23 ± 6 nM.IFN-λs (1, 2, or 3) or the antiretrovirals (AZT, Efavirenz, Indinavir, and Enfuvirtide) significantly inhibita the expression of HIV p24 antigen and Gag gene in macrophages. IFN-λs (1, 2, or 3) also enhanced the anti-HIV (Bal) effect of AZT, Efavirenz, Indinavir, and Enfuvirtide.
Enfuvirtide (T20; DP178) acetate is an anti-HIV-1 fusion inhibitor peptide.
体内研究：
Enfuvirtide has a T1/2 of 3.8 h.
体外研究：
A cell-cell fusion assay reveals that the effective concentration for achieving 50% inhibition (IC50) of Enfuvirtide is 23 ± 6 nM.IFN-λs (1, 2, or 3) or the antiretrovirals (AZT, Efavirenz, Indinavir, and Enfuvirtide) significantly inhibita the expression of HIV p24 antigen and Gag gene in macrophages. IFN-λs (1, 2, or 3) also enhanced the anti-HIV (Bal) effect of AZT, Efavirenz, Indinavir, and Enfuvirtide.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备